These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pathogenesis of acne. Toyoda M; Morohashi M Med Electron Microsc; 2001 Mar; 34(1):29-40. PubMed ID: 11479771 [TBL] [Abstract][Full Text] [Related]
8. Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies. Omer H; McDowell A; Alexeyev OA Clin Dermatol; 2017; 35(2):118-129. PubMed ID: 28274348 [TBL] [Abstract][Full Text] [Related]
9. Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study. Verde L; Cacciapuoti S; Caiazzo G; Megna M; Martora F; Cavaliere A; Mattera M; Maisto M; Tenore GC; Colao A; Savastano S; Muscogiuri G; Barrea L J Transl Med; 2024 Feb; 22(1):149. PubMed ID: 38350939 [TBL] [Abstract][Full Text] [Related]
10. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895 [TBL] [Abstract][Full Text] [Related]
11. Acne and diet: facts and controversies. Rezaković S; Bukvić Mokos Z; Basta-Juzbašić A Acta Dermatovenerol Croat; 2012; 20(3):170-4. PubMed ID: 23069302 [TBL] [Abstract][Full Text] [Related]
12. Supplementation with medium-chain fatty acids increases body weight loss during very low-calorie ketogenic diet: a retrospective analysis in a real-life setting. Vetrani C; Verde L; Savastano S; Colao A; Muscogiuri G; Barrea L J Transl Med; 2023 Jan; 21(1):29. PubMed ID: 36647097 [TBL] [Abstract][Full Text] [Related]
13. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris. Liu PF; Hsieh YD; Lin YC; Two A; Shu CW; Huang CM Curr Drug Metab; 2015; 16(4):245-54. PubMed ID: 26264195 [TBL] [Abstract][Full Text] [Related]
14. Skin barrier and microbiome in acne. Rocha MA; Bagatin E Arch Dermatol Res; 2018 Apr; 310(3):181-185. PubMed ID: 29147769 [TBL] [Abstract][Full Text] [Related]
15. From pathogenesis of acne vulgaris to anti-acne agents. Cong TX; Hao D; Wen X; Li XH; He G; Jiang X Arch Dermatol Res; 2019 Jul; 311(5):337-349. PubMed ID: 30859308 [TBL] [Abstract][Full Text] [Related]
16. Acne sans P. acnes. Shaheen B; Gonzalez M J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):1-10. PubMed ID: 22458782 [TBL] [Abstract][Full Text] [Related]
17. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Kim J Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063 [TBL] [Abstract][Full Text] [Related]
18. Modern management of acne. Cooper AJ; Harris VR Med J Aust; 2017 Jan; 206(1):41-45. PubMed ID: 28076744 [TBL] [Abstract][Full Text] [Related]